Last reviewed · How we verify

NCT03763201: GITR

Glucocorticoid-induced Tumour Necrosis Factor Receptor Related Protein (GITR) in Rheumatoid Arthritis

Status unknown Last updated 7 July 2020
What this trial tests

trial testing measurement of GITR in Rheumatoid Arthritis in 50 participants. Status unknown.

Timeline
8 November 2018
Primary endpoint
15 September 2020
15 September 2020

Quick facts

Lead sponsorBenha University
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment50
Start date8 November 2018
Primary completion15 September 2020
Estimated completion15 September 2020
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Benha University

Who can join

16 and older, any sex, with Rheumatoid Arthritis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aimed to measure serum and synovial fluid (SF) levels of GITR in patients with recent onset RA before and after initiation of therapy

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Rheumatoid Arthritis

Currently open trials in the same condition.

Other Benha University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03763201.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing